Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04046562
Other study ID # 14-079
Secondary ID 1R21DK117221
Status Recruiting
Phase N/A
First received
Last updated
Start date August 14, 2019
Est. completion date May 2025

Study information

Verified date June 2024
Source Connecticut Children's Medical Center
Contact Melissa Santos, PhD
Phone 860-837-6739
Email Msantos@connecticutchildrens.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pediatric weight management efficacy is impacted by failure to complete treatment protocols and, for those that do complete treatment, a return to unhealthy behaviors. This project tests whether treating pain, a common comorbid condition to pediatric obesity, will enhance treatment. This study will generate results that can be translated into immediate improvements in care for families seeking treatment for pediatric obesity.


Description:

Childhood obesity is a major public health crisis in the United States, affecting 16.9% of youth aged 2-19 and 20.5% of youth aged 12-19. While current family-based interventions are effective in reducing body mass index (BMI) in adolescents; the majority of adolescents regain their excess weight within 2 years. In addition, there is a high rate of drop out from weight management programs, with 27% to 73% of families not completing the full treatment protocol. One possible mechanism influencing pediatric weight management outcomes is chronic pain. Although chronic pain affects 25 to 46% of all youth, among youth with obesity, the prevalence is upwards of 70%. The causal relationship between pain and obesity is not well understood. In some cases, chronic pain may be a precipitant that causes youth to develop obesity by limiting their activities or altering their eating habits. A more common scenario is that obesity places mechanical stresses on the body that can cause pain. With time, pain may become "centralized." Either mechanism may impact youth's participation in a weight management program. However, interventions that address the relationship between chronic pain and obesity in youth are needed, yet no such interventions exist. We expect that co-treating these conditions -obesity and pain- rather than treating just the obesity, will lead to improved pediatric weight management outcomes. The proposed study will take place at the Pediatric Obesity Center at Connecticut Children's Medical Center (CCMC), as an adjunct to our Fit5 program. Fit5 is CCMC's family-based, group weight management treatment program for youth between the ages of 10-18. Consisting of 13 sessions, this multidisciplinary program focuses on behavior changes, nutrition education and physical activity within a cognitive behavioral therapy (CBT) framework. A brief 4 session adjunctive CBT intervention, Pain and Weight treatment (PAW), will be trialed in a group of youth entering weight management treatment and endorsing musculoskeletal pain. This will be done in three phases. First a focus group will be held to review the PAW curriculum which has already been created for this study. In phase two, a small randomized (n = 25 per condition) controlled trial (RCT) will be conducted to pilot PAW. Finally, exit interviews to obtain preliminary feasibility, acceptability and retention data on PAW as compared to an information only control condition will be conducted. There is much work that continues to be needed to improve treatment for youth with obesity. The findings of this study will advance a line of research much needed to better understand outcomes and treatment for adolescents with obesity by shifting from focusing on obesity as an independent condition, and instead, treating it in the context of its comorbid conditions that may be important determinants of engagement, adherence, and outcomes. This proposal will focus on pain and obesity as a model with the intention that this could expand to other comorbidities such as sleep disturbances. The pilot data obtained through this R21 grant proposal will be used to modify the intervention and to seek R01 funding to support a large scale RCT of PAW.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date May 2025
Est. primary completion date May 2025
Accepts healthy volunteers No
Gender All
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria: - Males and females between 12 and 18 years of age - Ability to speak, write and read English - A parent or guardian who speaks, writes and reads English - Signed consent and assent from the child and parent - Enrollment in a weight management program - Score greater than 3 on the Pain Burden Inventory at screening (in order to recruit adolescents who experience more than just general aches and pains). - Youth reporting musculoskeletal pain Exclusion Criteria: - Parent or guardian unable to participate - Patients on weight reducing medications - Severe psychiatric illness (i.e., suicidal or hospitalization within past 6 months) - Medical conditions such as Type 1 diabetes

Study Design


Intervention

Behavioral:
PAW
Pain and Weight Treatment plus standard of care
Pain Education
Pain Education plus standard of care

Locations

Country Name City State
United States Connecticut Children's Medical Center Hartford Connecticut

Sponsors (2)

Lead Sponsor Collaborator
Connecticut Children's Medical Center National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean difference in session attendance between groups The number of sessions of fit5 attended will be compared between the group attending PAW and those in the information control group. Through the 13 weeks that comprise fit5
Secondary The feasibility and acceptability of the PAW intervention will be examined Via exit interviews At the exit interviews, we will inquire with families whether 4 sessions felt sufficient, whether they would have liked more or less sessions and when they would have liked sessions scheduled. At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Depressed mood: The Center for Epidemiological Studies Depression Scale for Children (CES-DC)
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Eating behaviors (EAH): Three Factor Eating Questionnaire - R18
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Pain symptoms: The Pain Frequency - Severity - Duration Scale
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Pain symptoms: The Adolescent Pediatric Pain Tool
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Self-confidence: Readiness Ruler
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Eating behaviors: Eating Behaviors Questionnaire
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Behavior: The Pediatric Symptom Checklist 17 item (PSC-17)
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Quality of life: Sizing me up
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Quality of life: Sizing them up
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Pain symptoms: The Child Activity Limitations Interview questionnaire
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Pain symptoms: The Child Activity Limitations Interview questionnaire Parent version
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Pain symptoms: Pain Burden Interview
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Sleep: Adolescent Sleep-Wake Scale
At the conclusion of the 13 weeks of the program
Secondary The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires. Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction.
Medical: Youth will have their height, weight, BMI and BMI z-score calculated pre and post program completion as well as an assessment of their medical comorbidities.
At the conclusion of the 13 weeks of the program
See also
  Status Clinical Trial Phase
Completed NCT05452499 - Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae N/A
Recruiting NCT05037682 - Pain and Opioid Management in Older Adults N/A
Completed NCT04080037 - Assessing Opioid Care Practices Using CPV Patient Simulation Modules N/A
Recruiting NCT05382962 - iCanCope With Post-Operative Pain (iCanCope PostOp) N/A
Recruiting NCT04285112 - SPRINT: Signature for Pain Recovery IN Teens
Active, not recruiting NCT04850079 - EHR Precision Drug Treatment in Neonates
Completed NCT03272139 - Interscalene Block Versus Superior Trunk Block Phase 4
Completed NCT03271151 - Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty Phase 4
Completed NCT03886142 - Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis N/A
Recruiting NCT05761392 - APP-based Precise Management System of Chronic Intractable Pain N/A
Recruiting NCT05877157 - Pain AND Opioids After Surgery
Completed NCT03947749 - Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain
Completed NCT03280017 - Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain Phase 4
Recruiting NCT04874038 - Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN) Phase 3
Completed NCT04280796 - Changes in Affective Pain Processing in Human Volunteers N/A
Withdrawn NCT05125978 - Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain Phase 2
Not yet recruiting NCT04328805 - Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome. Phase 4
Completed NCT04976738 - A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain Phase 1/Phase 2
Completed NCT04089618 - Meditation Based Lifestyle Modification in Chronic Pain N/A
Recruiting NCT05699837 - Alpha Entrainment for Pain and Sleep (Extension) N/A

External Links